[1] Li H, Zhao H, Yu J, et al. Increased prevalence of regulatory T cells in the lung cancer microenvironment: a role of thymic stromal lymphopoietin[J]. Cancer Immunol Immunother, 2011,60:1587-1596. [2] Smith PA, Kohli LM, Wood KL, et al. Cytometric analysis of BAL T cells labeled with a standardized antibody cocktail correlates with immunohistochemical staining[J]. Cytometry B Clin Cytom, 2006, 70: 170-178. [3] Clark WH, Elder DE, Guerry D 4th, et al. Model predicting survival in stage I melanoma based on tumor progression[J] J Natl Cancer Inst, 1989, 24:1893-1904. [4] Thompson LD, Wieneke JA, Miettinen M. Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system[J]. Am J Surg Pathol, 2003, 5:594-611. [5] Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society[J]. Cancer, 1998, 8:1664-1678. [6] Han F, Liu HQ, Wang SY. Expression of CD117, MITF and NAT10 and their prognostic values in sinonasal mucosal melanoma[J]. Zhonghua Bing Li Xue Za Zhi, 2018, 12:931-935. [7] Gal TJ, Silver N, Huang B. Demographics and treatment trends in sinonasal mucosal melanoma[J]. Laryngoscope, 2011, 9:2026-2033. [8] Fridman WH, Zitvogel L, Sautès-Fridman C, et al. The immune contexture in cancer prognosis and treatment[J] Nat Rev Clin Oncol, 2017, 12:717-734. [9] Barnes TA, Amir E. HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer[J]. Br J Cancer, 2017, 4:451-460. [10] Ladányi A. Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma[J]. Pigment Cell Melanoma Res, 2015, 5:490-500. [11] Schnell A, Schmidl C, Herr W, et al. The peripheral and intratumoral immune cell landscape in cancer patients: a proxy for tumor biology and a tool for outcome prediction[J].Biomedicines, 2018,6:25. doi: 10.3390/biomedicines6010025. [12] Fridman WH, Galon J, Pagès F, et al. Prognostic and predictive impact of intra- and peritumoral immune infiltrates[J]. Cancer Res, 2011, 17: 5601-5605. [13] Weiss SA, Han SW, Lui K, et al. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma[J]. Hum Pathol, 2016, 57: 116-125. |